- Home
- Coronavirus Advice
- Coronavirus: latest update
- Covid-19 vaccine (BioNtec/Pfizer vaccine)
- Coronavirus: latest update
- Coronavirus: latest government advice on shielding
- Coronavirus: latest psychology update
- Coronavirus: psychology update for Mental Health Awareness Week
- Coronavirus: psychology update
- Coronavirus: latest psychology advice
- Coronavirus: psychology update
- Coronavirus: latest psychological advice for patients and families
- Coronavirus: latest psychological advice (FACE COVID)
- Coronavirus: Mental Health and Well-being
- Our Science Home Page
- Patient And Public
- What are mitochondria?
- About Our Clinic
- General information about mitochondrial disease
- Mitochondrial Reproductive Options
- Specific conditions
- Large-scale mitochondrial DNA deletions
- Neurogenic weakness, Ataxia, and Retinitis Pigmentosa (NARP)
- Multiple mitochondrial DNA deletions
- Mitochondrial Neuro-gastro-intestinal encephalopathy (MNGIE)
- Myoclonic Epilepsy and Ragged Red Fibres (MERRF 8344 A>G)
- Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS) 3243 A>G mutation
- Leigh syndrome
- Mitochondrial DNA depletion syndrome (MDDS)
- Alpers’ syndrome
- Our Patient Days
- Mitonews
- Fundraising
- Clinical Professionals
- Clinical Guidelines
- Mitochondrial Patient Cohort
- Engagement
- Team members
- Principal Investigators
- Professor Zofia Chrzanowska-Lightowlers
- Dr Grainne Gorman
- Dr Laura Greaves
- Dr Gavin Hudson
- Professor Mary Herbert
- Professor Robert Lightowlers
- Professor Robert McFarland
- Dr Brendan Payne
- Prof Robert Taylor
- Prof Sir Doug Turnbull
- Dr Tom Nicholls
- Dr Amy Reeve
- Dr Oliver Russell
- Dr Amy Vincent
- Dr Sarah Pickett
- Dr Yi Shiau Ng
- Dr Charlotte Alston
- Post Doctoral Scientists
- Clinical Team Members
- Associated Researchers
- NHS Diagnostic Laboratory Team Members
- Post Graduate Students
- Administrative and Technical
- Principal Investigators
- WCMR Seminars
- Contact Us
The Wellcome Trust Centre for Mitochondrial Research, based in Newcastle University, was established in May 2012 with the aim of developing a seamlessly integrated programme of basic and clinical mitochondrial disease research. We are a multi-disciplinary team who aim to not only push forward our understanding of mitochondrial disease mechanisms, but to also train future generations of exceptional young researchers. To find out more about our team members please click on the links to the left.
